Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

RFA-AI-23-021: Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)

Closed Closed June 8, 2023 Opportunity RFA-AI-23-021

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.

National Institutes of Health offered grants of up to $1.5 million to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on June 8, 2023.

From the official notice on Grants.gov, last changed March 16, 2023. Checked November 7, 2026.

About this NIH notice

Projects funded under RFA-AI-23-021 were run by National Institute of Allergy and Infectious Diseases (NIAID, 1 project). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read RFA-AI-23-021 in the NIH Guide.

Key dates

PostedMarch 16, 2023
DeadlineJune 8, 2023
Archived by Grants.govJuly 14, 2023

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

This Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to establish a Coordination and Data Sharing Center (CDSC) in support of the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers. Together, the CDSC and ReVAMPP Centers will form the ReVAMPP Network. The purpose of the CDSC is to support, coordinate, and manage ongoing and planned activities within the ReVAMPP Network. The CDSC is expected to establish and maintain a collaborative ReVAMPP Network platform for data sharing as needed to harmonize reagents, assays, animal models and exchange knowledge on structure/function-based vaccine solutions and antigen/immunogen design as well as assess the utility of vaccine technology platforms for virus families studied under the ReVAMPP Centers. The CDSC is also expected to facilitate effective communications across the ReVAMPP Centers by scheduling, and managing all meetings, tracking overall network progress and outputs, developing opportunities for collaboration among the Centers such as establishing working groups, and under the direction of NIAID, collating information and facilitating exchange with other NIAID/NIH programs, U.S. Government (USG)partners, and other key stakeholders, including the World Health Organization (WHO), Bill and Melinda Gates Foundation (BMGF), and Coalition for Epidemic Preparedness Innovations (CEPI) among others as appropriate.

Category: Health.

Funded under RFA-AI-23-021 so far

NIH funded 1 project under RFA-AI-23-021 in fiscal 2024, at 1 institution. The median yearly award was $8.0 million.

Recently funded projects
ProjectInstitutionFiscal yearAward
Coordinating and Data Sharing Center - R&D of Vaccines and Antibodies for Pandemic Preparedness (ReVAMPP) UG3Research Triangle Institute2024$8.0 million

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Allergy and Infectious Diseases Research grants before

From fiscal 2021 to 2025, Allergy and Infectious Diseases Research (93.855) awarded $22 billion across 13,282 grant awards, an average of $1.6 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Fred Hutchinson Cancer CenterWashington85$938 million
Duke UniversityNorth Carolina230$781 million
University of California, Los AngelesCalifornia138$745 million
The Johns Hopkins UniversityMaryland321$668 million
Emory UniversityGeorgia282$650 million

Top states: California ($3.4 billion), Massachusetts ($2.1 billion), Washington ($1.9 billion), New York ($1.8 billion), North Carolina ($1.5 billion).

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-AI-23-021 still open?

No. It closed on June 8, 2023.

Who can apply for Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)?

Closed June 8, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

Awards of up to $1.5 million each.

Who has been funded under RFA-AI-23-021?

NIH RePORTER lists 1 project funded under RFA-AI-23-021 in fiscal 2024, at 1 institution.

Who has won Allergy and Infectious Diseases Research grants before?

The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.

Similar open grants